ID   MUTA_HUMAN              Reviewed;         750 AA.
AC   P22033; A8K953; Q5SYZ3; Q96B11; Q9UD64;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=Methylmalonyl-CoA mutase, mitochondrial;
DE            Short=MCM;
DE            EC=5.4.99.2 {ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:28101778};
DE   AltName: Full=Methylmalonyl-CoA isomerase;
DE   Flags: Precursor;
GN   Name=MUT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANTS
RP   HIS-532 AND VAL-671.
RC   TISSUE=Liver;
RX   PubMed=2567699; DOI=10.1016/0888-7543(89)90300-5;
RA   Jansen R., Kalousek F., Fenton W.A., Rosenberg L.E., Ledley F.D.;
RT   "Cloning of full-length methylmalonyl-CoA mutase from a cDNA library
RT   using the polymerase chain reaction.";
RL   Genomics 4:198-205(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-532 AND VAL-671.
RX   PubMed=1980486; DOI=10.1016/0888-7543(90)90259-W;
RA   Nham S.U., Wilkemeyer M.F., Ledley F.D.;
RT   "Structure of the human methylmalonyl-CoA mutase (MUT) locus.";
RL   Genomics 8:710-716(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-671.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-499 AND
RP   VAL-671.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-499 AND
RP   VAL-671.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-481, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANTS MMAM ARG-105 AND GLU-377, AND INVOLVEMENT IN MMAM.
RX   PubMed=1977311;
RA   Jansen R., Ledley F.D.;
RT   "Heterozygous mutations at the mut locus in fibroblasts with mut0
RT   methylmalonic acidemia identified by polymerase-chain-reaction cDNA
RT   cloning.";
RL   Am. J. Hum. Genet. 47:808-814(1990).
RN   [10]
RP   VARIANT MMAM HIS-93.
RX   PubMed=1670635; DOI=10.1172/JCI114972;
RA   Raff M.L., Crane A.M., Jansen R., Ledley F.D., Rosenblatt D.S.;
RT   "Genetic characterization of a MUT locus mutation discriminating
RT   heterogeneity in mut0 and mut- methylmalonic aciduria by interallelic
RT   complementation.";
RL   J. Clin. Invest. 87:203-207(1991).
RN   [11]
RP   VARIANT MMAM VAL-717, AND VARIANT VAL-671.
RX   PubMed=1351030; DOI=10.1007/BF00220536;
RA   Crane A.M., Martin L.S., Valle D., Ledley F.D.;
RT   "Phenotype of disease in three patients with identical mutations in
RT   methylmalonyl CoA mutase.";
RL   Hum. Genet. 89:259-264(1992).
RN   [12]
RP   VARIANT MMAM VAL-717, AND VARIANT VAL-671.
RX   PubMed=1346616; DOI=10.1172/JCI115597;
RA   Crane A.M., Jansen R., Andrews E.R., Ledley F.D.;
RT   "Cloning and expression of a mutant methylmalonyl coenzyme A mutase
RT   with altered cobalamin affinity that causes mut- methylmalonic
RT   aciduria.";
RL   J. Clin. Invest. 89:385-391(1992).
RN   [13]
RP   VARIANTS MMAM CYS-626; GLU-630; ASP-648 AND TRP-694, AND VARIANT
RP   HIS-532.
RX   PubMed=7912889;
RA   Crane A.M., Ledley F.D.;
RT   "Clustering of mutations in methylmalonyl CoA mutase associated with
RT   mut-methylmalonic acidemia.";
RL   Am. J. Hum. Genet. 55:42-50(1994).
RN   [14]
RP   VARIANTS MMAM ARG-623 AND ARG-703.
RX   PubMed=7909321; DOI=10.1172/JCI117166;
RA   Qureshi A.A., Crane A.M., Matiaszuk N.V., Resvani I., Ledley F.D.,
RA   Rosenblatt D.S.;
RT   "Cloning and expression of mutations demonstrating intragenic
RT   complementation in mut0 methylmalonic aciduria.";
RL   J. Clin. Invest. 93:1812-1819(1994).
RN   [15]
RP   VARIANTS MMAM VAL-94; ASN-231; HIS-369; ARG-623; ARG-678; TRP-694 AND
RP   VAL-717.
RX   PubMed=9285782; DOI=10.1093/hmg/6.9.1457;
RA   Janata J., Kogekar N., Fenton W.A.;
RT   "Expression and kinetic characterization of methylmalonyl-CoA mutase
RT   from patients with the mut- phenotype: evidence for naturally
RT   occurring interallelic complementation.";
RL   Hum. Mol. Genet. 6:1457-1464(1997).
RN   [16]
RP   REVIEW ON VARIANTS.
RX   PubMed=8990001;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<1::AID-HUMU1>3.3.CO;2-G;
RA   Ledley F.D., Rosenblatt D.S.;
RT   "Mutations in mut methylmalonic acidemia: clinical and enzymatic
RT   correlations.";
RL   Hum. Mutat. 9:1-6(1997).
RN   [17]
RP   VARIANT MMAM VAL-717, AND VARIANT VAL-671.
RX   PubMed=9452100;
RA   Adjalla C.E., Hosack A.R., Matiaszuk N.V., Rosenblatt D.S.;
RT   "A common mutation among blacks with mut- methylmalonic aciduria.";
RL   Hum. Mutat. Suppl. 1:S248-S250(1998).
RN   [18]
RP   VARIANTS MMAM GLU-191; GLN-228; VAL-312; LEU-346 DEL; GLY-633; LEU-684
RP   INS AND ARG-685.
RX   PubMed=9554742;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:4<270::AID-HUMU3>3.0.CO;2-T;
RA   Adjalla C.E., Hosack A.R., Gilfix B.M., Lamothe E., Sun S., Chan A.,
RA   Evans S., Matiaszuk N.V., Rosenblatt D.S.;
RT   "Seven novel mutations in mut methylmalonic aciduria.";
RL   Hum. Mutat. 11:270-274(1998).
RN   [19]
RP   VARIANTS MMAM VAL-137; SER-174; ARG-203; HIS-218; PRO-535 AND ARG-627.
RX   PubMed=10923046;
RX   DOI=10.1002/1098-1004(200008)16:2<179::AID-HUMU17>3.0.CO;2-R;
RA   Fuchshuber A., Mucha B., Baumgartner E.R., Vollmer M., Hildebrandt F.;
RT   "mut0 methylmalonic acidemia: eleven novel mutations of the
RT   methylmalonyl CoA mutase including a deletion-insertion mutation.";
RL   Hum. Mutat. 16:179-179(2000).
RN   [20]
RP   VARIANT MMAM TYR-219, AND VARIANTS THR-499 AND VAL-671.
RX   PubMed=11350191; DOI=10.1006/mgme.2001.3166;
RA   Berger I., Shaag A., Anikster Y., Baumgartner E.R., Bar-Meir M.,
RA   Joseph A., Elpeleg O.N.;
RT   "Mutation analysis of the MCM gene in Israeli patients with mut(0)
RT   disease.";
RL   Mol. Genet. Metab. 73:107-110(2001).
RN   [21]
RP   VARIANTS MMAM HIS-108; LEU-148; ASN-156; VAL-158; GLU-191; ARG-203;
RP   SER-215; TYR-219; ASN-262; PRO-293; PHE-328; CYS-587; THR-615;
RP   ASN-621; ARG-623; ARG-624; ARG-627; GLU-637; ILE-638; TYR-640;
RP   ARG-642; TRP-694 AND LYS-700.
RX   PubMed=15643616; DOI=10.1002/humu.20128;
RA   Acquaviva C., Benoist J.-F., Pereira S., Callebaut I., Koskas T.,
RA   Porquet D., Elion J.;
RT   "Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40
RT   European patients affected by mut(o) and mut- forms of methylmalonic
RT   acidemia: identification of 29 novel mutations in the MUT gene.";
RL   Hum. Mutat. 25:167-176(2005).
RN   [22]
RP   VARIANTS MMAM ARG-109; GLU-191; TYR-219; THR-324; PRO-328; CYS-616 AND
RP   ARG-617, AND VARIANT VAL-69.
RX   PubMed=15781192; DOI=10.1016/j.ymgme.2004.11.011;
RA   Martinez M.A., Rincon A., Desviat L.R., Merinero B., Ugarte M.,
RA   Perez B.;
RT   "Genetic analysis of three genes causing isolated methylmalonic
RT   acidemia: identification of 21 novel allelic variants.";
RL   Mol. Genet. Metab. 84:317-325(2005).
RN   [23]
RP   VARIANTS MMAM LEU-86; GLU-87; HIS-93; ARG-94; VAL-94; ARG-95; ARG-105;
RP   CYS-108; GLY-108; HIS-108; SER-145; SER-174; VAL-186; LYS-189;
RP   GLU-191; GLU-197; ARG-203; CYS-215; SER-215; HIS-218; TYR-219;
RP   GLN-228; ILE-230; ASN-231; ASN-262; TYR-265; SER-281; GLU-291;
RP   SER-305; PHE-306; VAL-312; CYS-316; THR-324; LEU-346 DEL; ARG-347;
RP   TYR-350; CYS-369; HIS-369; PRO-370; GLU-377; HIS-383; PRO-383;
RP   ARG-386; ASN-386; HIS-388; SER-389 DEL; ILE-412 DEL; ARG-426; ASP-427;
RP   PRO-518; TYR-560; ARG-566; SER-573; ARG-615; CYS-616; ARG-623;
RP   GLU-630; GLY-633; ARG-637; ARG-642; ARG-678; ARG-685; TRP-694;
RP   LYS-700; ARG-703 AND VAL-717, AND VARIANTS VAL-69; THR-499; HIS-532
RP   AND VAL-671.
RX   PubMed=16281286; DOI=10.1002/humu.20258;
RA   Worgan L.C., Niles K., Tirone J.C., Hofmann A., Verner A., Sammak A.,
RA   Kucic T., Lepage P., Rosenblatt D.S.;
RT   "Spectrum of mutations in mut methylmalonic acidemia and
RT   identification of a common Hispanic mutation and haplotype.";
RL   Hum. Mutat. 27:31-43(2006).
RN   [24]
RP   VARIANTS MMAM CYS-100; HIS-108; VAL-137; TYR-143; LEU-148; GLU-191;
RP   ARG-203; HIS-218; TYR-219; ASN-231; PRO-288; PHE-328; PHE-344;
RP   SER-366; HIS-369; GLU-454; THR-615; GLU-630; GLY-633; LEU-694; TRP-694
RP   AND LYS-700.
RX   PubMed=17113806; DOI=10.1016/j.ymgme.2006.10.002;
RA   Lempp T.J., Suormala T., Siegenthaler R., Baumgartner E.R., Fowler B.,
RA   Steinmann B., Baumgartner M.R.;
RT   "Mutation and biochemical analysis of 19 probands with mut0 and 13
RT   with mut- methylmalonic aciduria: identification of seven novel
RT   mutations.";
RL   Mol. Genet. Metab. 90:284-290(2007).
RN   [25]
RP   VARIANTS MMAM VAL-69; ARG-109; GLU-191; PRO-328; PRO-358; CYS-369;
RP   CYS-616 AND ARG-617.
RX   PubMed=17957493; DOI=10.1007/s10545-007-0667-y;
RA   Merinero B., Perez B., Perez-Cerda C., Rincon A., Desviat L.R.,
RA   Martinez M.A., Sala P.R., Garcia M.J., Aldamiz-Echevarria L.,
RA   Campos J., Cornejo V., Del Toro M., Mahfoud A., Martinez-Pardo M.,
RA   Parini R., Pedron C., Pena-Quintana L., Perez M., Pourfarzam M.,
RA   Ugarte M.;
RT   "Methylmalonic acidaemia: examination of genotype and biochemical data
RT   in 32 patients belonging to mut, cblA or cblB complementation group.";
RL   J. Inherit. Metab. Dis. 31:55-66(2008).
RN   [26]
RP   VARIANT MMAM ARG-161.
RX   PubMed=19588269; DOI=10.1007/s10545-009-1141-9;
RA   Filippi L., Gozzini E., Cavicchi C., Morrone A., Fiorini P.,
RA   Donzelli G., Malvagia S., la Marca G.;
RT   "Insulin-resistant hyperglycaemia complicating neonatal onset of
RT   methylmalonic and propionic acidaemias.";
RL   J. Inherit. Metab. Dis. 32:S179-S186(2009).
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-671, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   VARIANTS MMAM GLY-137; TYR-219; SER-305; PHE-328; ILE-387; GLU-454;
RP   GLU-514; LEU-615; THR-615; VAL-625 AND PHE-674, AND VARIANTS THR-499;
RP   HIS-532 AND VAL-671.
RX   PubMed=22727635; DOI=10.1016/j.ymgme.2012.05.014;
RA   Duendar H., Oezguel R.K., Guezel-Ozantuerk A., Dursun A., Sivri S.,
RA   Aliefendioglu D., Coskun T., Tokatli A.;
RT   "Microarray based mutational analysis of patients with methylmalonic
RT   acidemia: identification of 10 no vel mutations.";
RL   Mol. Genet. Metab. 106:419-423(2012).
RN   [29]
RP   CHARACTERIZATION OF VARIANTS MMAM LEU-86; CYS-100; GLU-191; HIS-218;
RP   TYR-219; ASN-231; CYS-316; PHE-328; PHE-344; SER-366; HIS-369;
RP   ILE-387; ARG-426; SER-573; LEU-615; THR-615; GLY-633; ASP-648;
RP   LEU-694; TRP-694; LYS-700; VAL-717 AND PHE-736, CATALYTIC ACTIVITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=25125334; DOI=10.1002/humu.22633;
RA   Forny P., Froese D.S., Suormala T., Yue W.W., Baumgartner M.R.;
RT   "Functional characterization and categorization of missense mutations
RT   that cause methylmalonyl-CoA mutase (MUT) deficiency.";
RL   Hum. Mutat. 35:1449-1458(2014).
RN   [30]
RP   VARIANTS MMAM LYS-126; ARG-133; ASN-139; VAL-156; ARG-161; SER-187;
RP   ILE-189; GLU-205 DEL; ARG-230; ASP-276; ARG-284; GLU-284; ASP-325;
RP   LYS-326; LYS-388; LEU-424; GLU-426; VAL-552; PRO-618 AND GLY-625, AND
RP   CHARACTERIZATION OF VARIANTS MMAM HIS-93; ARG-133; ARG-161; ILE-189;
RP   GLU-191; ARG-203; ARG-230; PRO-288; SER-305; GLU-377; LYS-388;
RP   LEU-424; GLU-426; LEU-615; THR-615; ARG-624; VAL-625; GLY-625; PHE-674
RP   AND TRP-694.
RX   PubMed=27167370; DOI=10.1002/humu.23013;
RA   Forny P., Schnellmann A.S., Buerer C., Lutz S., Fowler B.,
RA   Froese D.S., Baumgartner M.R.;
RT   "Molecular genetic characterization of 151 mut-type methylmalonic
RT   aciduria patients and identification of 41 novel mutations in MUT.";
RL   Hum. Mutat. 37:745-754(2016).
RN   [31]
RP   VARIANTS MMAM HIS-93; CYS-108; CYS-110; SER-174; SER-215; SER-364;
RP   ILE-387; PRO-692 AND TRP-694.
RX   PubMed=26615597; DOI=10.1007/8904_2014_297;
RA   Imtiaz F., Al-Mubarak B.M., Al-Mostafa A., Al-Hamed M., Allam R.,
RA   Al-Hassnan Z., Al-Owain M., Al-Zaidan H., Rahbeeni Z., Qari A.,
RA   Faqeih E.A., Alasmari A., Al-Mutairi F., Alfadhel M., Eyaid W.M.,
RA   Rashed M.S., Al-Sayed M.;
RT   "Spectrum of mutations in 60 Saudi patients with Mut methylmalonic
RT   acidemia.";
RL   JIMD Rep. 29:39-46(2016).
RN   [32]
RP   VARIANTS MMAM PRO-140; THR-141; VAL-161; GLY-309; THR-505; LYS-514;
RP   ARG-597 AND ASP-723, CHARACTERIZATION OF VARIANTS MMAM PRO-140;
RP   THR-141; VAL-161; GLY-309; THR-505; LYS-514; ARG-597 AND ASP-723, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=28101778; DOI=10.1007/s12519-016-0085-z;
RA   Han L.S., Huang Z., Han F., Wang Y., Gong Z.W., Gu X.F.;
RT   "Eight novel MUT loss-of-function missense mutations in Chinese
RT   patients with isolated methylmalonic academia.";
RL   World J. Pediatr. 0:0-0(2017).
CC   -!- FUNCTION: Involved in the degradation of several amino acids, odd-
CC       chain fatty acids and cholesterol via propionyl-CoA to the
CC       tricarboxylic acid cycle. MCM has different functions in other
CC       species.
CC   -!- CATALYTIC ACTIVITY: (R)-methylmalonyl-CoA = succinyl-CoA.
CC       {ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:28101778}.
CC   -!- COFACTOR:
CC       Name=adenosylcob(III)alamin; Xref=ChEBI:CHEBI:18408;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.7 nM for adenosylcob(III)alamin
CC         {ECO:0000269|PubMed:25125334};
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- DISEASE: Methylmalonic aciduria type mut (MMAM) [MIM:251000]: An
CC       often fatal disorder of organic acid metabolism. Common clinical
CC       features include lethargy, vomiting, failure to thrive, hypotonia,
CC       neurological deficit and early death. Two forms of the disease are
CC       distinguished by the presence (mut-) or absence (mut0) of residual
CC       enzyme activity. Mut0 patients have more severe neurological
CC       manifestations of the disease than do MUT- patients. MMAM is
CC       unresponsive to vitamin B12 therapy. {ECO:0000269|PubMed:10923046,
CC       ECO:0000269|PubMed:11350191, ECO:0000269|PubMed:1346616,
CC       ECO:0000269|PubMed:1351030, ECO:0000269|PubMed:15643616,
CC       ECO:0000269|PubMed:15781192, ECO:0000269|PubMed:16281286,
CC       ECO:0000269|PubMed:1670635, ECO:0000269|PubMed:17113806,
CC       ECO:0000269|PubMed:17957493, ECO:0000269|PubMed:19588269,
CC       ECO:0000269|PubMed:1977311, ECO:0000269|PubMed:22727635,
CC       ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:26615597,
CC       ECO:0000269|PubMed:27167370, ECO:0000269|PubMed:28101778,
CC       ECO:0000269|PubMed:7909321, ECO:0000269|PubMed:7912889,
CC       ECO:0000269|PubMed:9285782, ECO:0000269|PubMed:9452100,
CC       ECO:0000269|PubMed:9554742}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the methylmalonyl-CoA mutase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Methylmalonyl coenzyme A mutase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Methylmalonyl_Coenzyme_A_mutase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M65131; AAA59569.1; -; mRNA.
DR   EMBL; M37510; AAA99226.1; -; Genomic_DNA.
DR   EMBL; M37499; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37500; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37501; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37503; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37504; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37505; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37506; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37507; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37508; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; M37509; AAA99226.1; JOINED; Genomic_DNA.
DR   EMBL; AK292568; BAF85257.1; -; mRNA.
DR   EMBL; BT007434; AAP36102.1; -; mRNA.
DR   EMBL; AL590668; CAI14311.1; -; Genomic_DNA.
DR   EMBL; BC016282; AAH16282.1; -; mRNA.
DR   CCDS; CCDS4924.1; -.
DR   PIR; A59145; A59145.
DR   RefSeq; NP_000246.2; NM_000255.3.
DR   RefSeq; XP_005249200.1; XM_005249143.3.
DR   UniGene; Hs.485527; -.
DR   PDB; 2XIJ; X-ray; 1.95 A; A=12-750.
DR   PDB; 2XIQ; X-ray; 1.95 A; A/B=12-750.
DR   PDB; 3BIC; X-ray; 2.60 A; A/B=12-750.
DR   PDBsum; 2XIJ; -.
DR   PDBsum; 2XIQ; -.
DR   PDBsum; 3BIC; -.
DR   ProteinModelPortal; P22033; -.
DR   SMR; P22033; -.
DR   BioGrid; 110680; 13.
DR   IntAct; P22033; 3.
DR   MINT; MINT-3009603; -.
DR   STRING; 9606.ENSP00000274813; -.
DR   DrugBank; DB00115; Cyanocobalamin.
DR   DrugBank; DB00200; Hydroxocobalamin.
DR   SwissLipids; SLP:000001254; -.
DR   iPTMnet; P22033; -.
DR   PhosphoSitePlus; P22033; -.
DR   BioMuta; MUT; -.
DR   DMDM; 317373575; -.
DR   EPD; P22033; -.
DR   MaxQB; P22033; -.
DR   PaxDb; P22033; -.
DR   PeptideAtlas; P22033; -.
DR   PRIDE; P22033; -.
DR   DNASU; 4594; -.
DR   Ensembl; ENST00000274813; ENSP00000274813; ENSG00000146085.
DR   GeneID; 4594; -.
DR   KEGG; hsa:4594; -.
DR   UCSC; uc003ozg.5; human.
DR   CTD; 4594; -.
DR   DisGeNET; 4594; -.
DR   GeneCards; MUT; -.
DR   GeneReviews; MUT; -.
DR   H-InvDB; HIX0005945; -.
DR   HGNC; HGNC:7526; MUT.
DR   HPA; HPA035971; -.
DR   HPA; HPA035972; -.
DR   MalaCards; MUT; -.
DR   MIM; 251000; phenotype.
DR   MIM; 609058; gene.
DR   neXtProt; NX_P22033; -.
DR   OpenTargets; ENSG00000146085; -.
DR   Orphanet; 79312; Vitamin B12-unresponsive methylmalonic acidemia type mut-.
DR   Orphanet; 289916; Vitamin B12-unresponsive methylmalonic acidemia type mut0.
DR   PharmGKB; PA31327; -.
DR   eggNOG; ENOG410IE7I; Eukaryota.
DR   eggNOG; COG1884; LUCA.
DR   eggNOG; COG2185; LUCA.
DR   GeneTree; ENSGT00390000011892; -.
DR   HOGENOM; HOG000003917; -.
DR   HOVERGEN; HBG006423; -.
DR   InParanoid; P22033; -.
DR   KO; K01847; -.
DR   OMA; GVNKYRP; -.
DR   OrthoDB; EOG091G02GM; -.
DR   PhylomeDB; P22033; -.
DR   TreeFam; TF313557; -.
DR   BioCyc; MetaCyc:HS07322-MONOMER; -.
DR   BRENDA; 5.4.99.2; 2681.
DR   Reactome; R-HSA-196741; Cobalamin (Cbl, vitamin B12) transport and metabolism.
DR   Reactome; R-HSA-3359475; Defective MMAA causes methylmalonic aciduria type cblA.
DR   Reactome; R-HSA-3359478; Defective MUT causes methylmalonic aciduria mut type.
DR   Reactome; R-HSA-71032; Propionyl-CoA catabolism.
DR   SABIO-RK; P22033; -.
DR   EvolutionaryTrace; P22033; -.
DR   GeneWiki; Methylmalonyl-CoA_mutase; -.
DR   GenomeRNAi; 4594; -.
DR   PRO; PR:P22033; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146085; -.
DR   CleanEx; HS_MUT; -.
DR   ExpressionAtlas; P22033; baseline and differential.
DR   Genevisible; P22033; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004494; F:methylmalonyl-CoA mutase activity; IMP:UniProtKB.
DR   GO; GO:0072341; F:modified amino acid binding; IDA:UniProtKB.
DR   GO; GO:0009235; P:cobalamin metabolic process; TAS:Reactome.
DR   GO; GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome.
DR   Gene3D; 3.20.20.240; -; 1.
DR   InterPro; IPR006159; Acid_CoA_mut_C.
DR   InterPro; IPR016176; Cbl-dep_enz_cat.
DR   InterPro; IPR006158; Cobalamin-bd.
DR   InterPro; IPR006099; MeMalonylCoA_mutase_a/b_cat.
DR   InterPro; IPR006098; MMCoA_mutase_a_cat.
DR   Pfam; PF02310; B12-binding; 1.
DR   Pfam; PF01642; MM_CoA_mutase; 1.
DR   SUPFAM; SSF51703; SSF51703; 1.
DR   SUPFAM; SSF52242; SSF52242; 1.
DR   TIGRFAMs; TIGR00640; acid_CoA_mut_C; 1.
DR   TIGRFAMs; TIGR00641; acid_CoA_mut_N; 1.
DR   PROSITE; PS51332; B12_BINDING; 1.
DR   PROSITE; PS00544; METMALONYL_COA_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cobalamin; Cobalt; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Isomerase; Metal-binding;
KW   Mitochondrion; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     32       Mitochondrion.
FT   CHAIN        33    750       Methylmalonyl-CoA mutase, mitochondrial.
FT                                /FTId=PRO_0000019293.
FT   DOMAIN      614    746       B12-binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00666}.
FT   METAL       627    627       Cobalt (cobalamin axial ligand).
FT                                {ECO:0000250}.
FT   MOD_RES      89     89       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   MOD_RES     212    212       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   MOD_RES     335    335       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   MOD_RES     343    343       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   MOD_RES     481    481       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     595    595       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   MOD_RES     602    602       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P16332}.
FT   VARIANT      69     69       I -> V (in MMAM; dbSNP:rs115923556).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_023472.
FT   VARIANT      86     86       P -> L (in MMAM; mut0 and mut-; no effect
FT                                on protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity;
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs769348060).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_026592.
FT   VARIANT      87     87       G -> E (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026593.
FT   VARIANT      93     93       R -> H (in MMAM; mut0; decreased
FT                                methylmalonyl-CoA mutase activity;
FT                                dbSNP:rs121918251).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:1670635,
FT                                ECO:0000269|PubMed:26615597,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_004409.
FT   VARIANT      94     94       G -> R (in MMAM; mut0;
FT                                dbSNP:rs727504022).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026594.
FT   VARIANT      94     94       G -> V (in MMAM; mut- and mut0;
FT                                dbSNP:rs535411418).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_022393.
FT   VARIANT      95     95       P -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026595.
FT   VARIANT     100    100       Y -> C (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity;
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs864309735).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_075379.
FT   VARIANT     105    105       W -> R (in MMAM; mut0;
FT                                dbSNP:rs121918249).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:1977311}.
FT                                /FTId=VAR_004410.
FT   VARIANT     108    108       R -> C (in MMAM; mut0;
FT                                dbSNP:rs121918257).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_026596.
FT   VARIANT     108    108       R -> G (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026597.
FT   VARIANT     108    108       R -> H (in MMAM; mut0;
FT                                dbSNP:rs483352778).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806}.
FT                                /FTId=VAR_022394.
FT   VARIANT     109    109       Q -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_023473.
FT   VARIANT     110    110       Y -> C (in MMAM; dbSNP:rs796052005).
FT                                {ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_075380.
FT   VARIANT     126    126       N -> K (in MMAM).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077210.
FT   VARIANT     133    133       G -> R (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077211.
FT   VARIANT     137    137       A -> G (in MMAM).
FT                                {ECO:0000269|PubMed:22727635}.
FT                                /FTId=VAR_075381.
FT   VARIANT     137    137       A -> V (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:10923046,
FT                                ECO:0000269|PubMed:17113806}.
FT                                /FTId=VAR_022395.
FT   VARIANT     139    139       D -> N (in MMAM; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077212.
FT   VARIANT     140    140       L -> P (in MMAM; decreased protein
FT                                expression; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078342.
FT   VARIANT     141    141       A -> T (in MMAM; decreased protein
FT                                expression).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078343.
FT   VARIANT     143    143       H -> Y (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:17113806}.
FT                                /FTId=VAR_075382.
FT   VARIANT     145    145       G -> S (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026598.
FT   VARIANT     148    148       S -> L (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:17113806}.
FT                                /FTId=VAR_022396.
FT   VARIANT     156    156       D -> N (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022397.
FT   VARIANT     156    156       D -> V (in MMAM; dbSNP:rs757000253).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077213.
FT   VARIANT     158    158       G -> V (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022398.
FT   VARIANT     161    161       G -> R (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:19588269,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077214.
FT   VARIANT     161    161       G -> V (in MMAM; decreased protein
FT                                expression).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078344.
FT   VARIANT     174    174       F -> S (in MMAM; mut0;
FT                                dbSNP:rs864309733).
FT                                {ECO:0000269|PubMed:10923046,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_022399.
FT   VARIANT     186    186       M -> V (in MMAM; mut-;
FT                                dbSNP:rs148331800).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026599.
FT   VARIANT     187    187       T -> S (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077215.
FT   VARIANT     189    189       N -> I (in MMAM; mut-; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity; dbSNP:rs200908035).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077216.
FT   VARIANT     189    189       N -> K (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026600.
FT   VARIANT     191    191       A -> E (in MMAM; mut- and mut0; affects
FT                                proper folding; reduced protein level;
FT                                decreased methylmalonyl-CoA mutase
FT                                activity; dbSNP:rs760782399).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:17957493,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:27167370,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004411.
FT   VARIANT     197    197       A -> E (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026601.
FT   VARIANT     203    203       G -> R (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity; dbSNP:rs778702777).
FT                                {ECO:0000269|PubMed:10923046,
FT                                ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_022400.
FT   VARIANT     205    205       Missing (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077217.
FT   VARIANT     215    215       G -> C (in MMAM; mut- and mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026602.
FT   VARIANT     215    215       G -> S (in MMAM; mut0;
FT                                dbSNP:rs121918258).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_022401.
FT   VARIANT     218    218       Q -> H (in MMAM; mut0 and mut-; no effect
FT                                on protein abundance; loss of
FT                                methylmalonyl-CoA mutase activity; alters
FT                                thermodynamic stability).
FT                                {ECO:0000269|PubMed:10923046,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_022402.
FT   VARIANT     219    219       N -> Y (in MMAM; mut0; no effect on
FT                                protein abundance; loss of methylmalonyl-
FT                                CoA mutase activity; dbSNP:rs121918256).
FT                                {ECO:0000269|PubMed:11350191,
FT                                ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_022403.
FT   VARIANT     228    228       R -> Q (in MMAM; mut0;
FT                                dbSNP:rs770810987).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004412.
FT   VARIANT     230    230       T -> I (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026603.
FT   VARIANT     230    230       T -> R (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077218.
FT   VARIANT     231    231       Y -> N (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity; strong
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs864309736).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_004413.
FT   VARIANT     262    262       S -> N (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_022404.
FT   VARIANT     265    265       H -> Y (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026604.
FT   VARIANT     276    276       E -> D (in MMAM; mut-; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077219.
FT   VARIANT     281    281       L -> S (in MMAM; mut0;
FT                                dbSNP:rs796052007).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026605.
FT   VARIANT     284    284       G -> E (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077220.
FT   VARIANT     284    284       G -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077221.
FT   VARIANT     288    288       S -> P (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_075383.
FT   VARIANT     291    291       G -> E (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026606.
FT   VARIANT     293    293       Q -> P (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022405.
FT   VARIANT     305    305       L -> S (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_026607.
FT   VARIANT     306    306       S -> F (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026608.
FT   VARIANT     309    309       W -> G (in MMAM; decreased protein
FT                                expression).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078345.
FT   VARIANT     312    312       G -> V (in MMAM; mut0;
FT                                dbSNP:rs864309734).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004414.
FT   VARIANT     316    316       Y -> C (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity; no
FT                                decreased affinity for
FT                                adenosylcob(III)alamin;
FT                                dbSNP:rs781474200).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_026609.
FT   VARIANT     324    324       A -> T (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_023474.
FT   VARIANT     325    325       G -> D (in MMAM).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077222.
FT   VARIANT     326    326       R -> K (in MMAM; unknown pathological
FT                                significance; dbSNP:rs758577372).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077223.
FT   VARIANT     328    328       L -> F (in MMAM; mut0; affects proper
FT                                folding; no effect on protein abundance;
FT                                loss of methylmalonyl-CoA mutase
FT                                activity; dbSNP:rs796052002).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_022406.
FT   VARIANT     328    328       L -> P (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_023475.
FT   VARIANT     344    344       S -> F (in MMAM; mut-; affects proper
FT                                folding; no effect on protein abundance;
FT                                loss of methylmalonyl-CoA mutase
FT                                activity; decreased affinity for
FT                                adenosylcob(III)alamin).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_075384.
FT   VARIANT     346    346       Missing (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004415.
FT   VARIANT     347    347       L -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026610.
FT   VARIANT     350    350       H -> Y (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026611.
FT   VARIANT     358    358       L -> P (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_077224.
FT   VARIANT     364    364       Y -> S (in MMAM; dbSNP:rs563776413).
FT                                {ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_075385.
FT   VARIANT     366    366       N -> S (in MMAM; mut-; no effect on
FT                                protein abundance; loss of methylmalonyl-
FT                                CoA mutase activity; decreased affinity
FT                                for adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs864309737).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_075386.
FT   VARIANT     368    368       V -> D (in MMAM).
FT                                /FTId=VAR_004416.
FT   VARIANT     369    369       R -> C (in MMAM; mut0;
FT                                dbSNP:rs772552898).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_026612.
FT   VARIANT     369    369       R -> H (in MMAM; mut- and mut0; no effect
FT                                on protein abundance; loss of
FT                                methylmalonyl-CoA mutase activity; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs564069299).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_004417.
FT   VARIANT     370    370       T -> P (in MMAM; mut0;
FT                                dbSNP:rs368790885).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026613.
FT   VARIANT     377    377       A -> E (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity; dbSNP:rs121918250).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:1977311,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_004418.
FT   VARIANT     383    383       Q -> H (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026614.
FT   VARIANT     383    383       Q -> P (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026615.
FT   VARIANT     386    386       H -> N (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026616.
FT   VARIANT     386    386       H -> R (in MMAM; mut0;
FT                                dbSNP:rs866933356).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_077225.
FT   VARIANT     387    387       T -> I (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity;
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability).
FT                                {ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_075387.
FT   VARIANT     388    388       N -> H (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026617.
FT   VARIANT     388    388       N -> K (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077226.
FT   VARIANT     389    389       Missing (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026618.
FT   VARIANT     412    412       Missing (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026619.
FT   VARIANT     424    424       P -> L (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077227.
FT   VARIANT     426    426       G -> E (in MMAM; mut-; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077228.
FT   VARIANT     426    426       G -> R (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity; strong
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs769922244).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_026620.
FT   VARIANT     427    427       G -> D (in MMAM; mut0;
FT                                dbSNP:rs753288303).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026621.
FT   VARIANT     454    454       G -> E (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:22727635}.
FT                                /FTId=VAR_075388.
FT   VARIANT     499    499       A -> T (in dbSNP:rs2229385).
FT                                {ECO:0000269|PubMed:11350191,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_022407.
FT   VARIANT     505    505       I -> T (in MMAM; decreased protein
FT                                expression; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078346.
FT   VARIANT     514    514       Q -> E (in MMAM; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22727635}.
FT                                /FTId=VAR_075389.
FT   VARIANT     514    514       Q -> K (in MMAM; decreased protein
FT                                expression).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078347.
FT   VARIANT     518    518       L -> P (in MMAM; mut0;
FT                                dbSNP:rs864309738).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026622.
FT   VARIANT     532    532       R -> H (in dbSNP:rs1141321).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:1980486,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:2567699,
FT                                ECO:0000269|PubMed:7912889}.
FT                                /FTId=VAR_004419.
FT   VARIANT     535    535       A -> P (in MMAM; mut0;
FT                                dbSNP:rs760183775).
FT                                {ECO:0000269|PubMed:10923046}.
FT                                /FTId=VAR_022408.
FT   VARIANT     552    552       A -> V (in MMAM; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077229.
FT   VARIANT     560    560       C -> Y (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026623.
FT   VARIANT     566    566       T -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026624.
FT   VARIANT     573    573       F -> S (in MMAM; mut-; affects proper
FT                                folding; no effect on protein abundance;
FT                                no effect on methylmalonyl-CoA mutase
FT                                activity; decreased affinity for
FT                                adenosylcob(III)alamin; does not alter
FT                                thermodynamic stability;
FT                                dbSNP:rs775593146).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_026625.
FT   VARIANT     587    587       Y -> C (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022409.
FT   VARIANT     597    597       I -> R (in MMAM; no changed in protein
FT                                expression; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078348.
FT   VARIANT     598    598       T -> A (in dbSNP:rs9473556).
FT                                /FTId=VAR_030495.
FT   VARIANT     615    615       P -> L (in MMAM; mut0; affects proper
FT                                folding; reduced strongly protein level).
FT                                {ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_075390.
FT   VARIANT     615    615       P -> R (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026626.
FT   VARIANT     615    615       P -> T (in MMAM; mut0; affects proper
FT                                folding; reduced strongly protein level;
FT                                loss of methylmalonyl-CoA mutase
FT                                activity). {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_022410.
FT   VARIANT     616    616       R -> C (in MMAM; mut0;
FT                                dbSNP:rs765284825).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_023476.
FT   VARIANT     617    617       L -> R (in MMAM).
FT                                {ECO:0000269|PubMed:15781192,
FT                                ECO:0000269|PubMed:17957493}.
FT                                /FTId=VAR_023477.
FT   VARIANT     618    618       L -> P (in MMAM).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077230.
FT   VARIANT     621    621       K -> N (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022411.
FT   VARIANT     623    623       G -> R (in MMAM; mut0;
FT                                dbSNP:rs121918254).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:7909321,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_004420.
FT   VARIANT     624    624       Q -> R (in MMAM; no effect on protein
FT                                abundance; dbSNP:rs768521956).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_022412.
FT   VARIANT     625    625       D -> G (in MMAM; mut0; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_077231.
FT   VARIANT     625    625       D -> V (in MMAM; mut0; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity).
FT                                {ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_075391.
FT   VARIANT     626    626       G -> C (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:7912889}.
FT                                /FTId=VAR_004421.
FT   VARIANT     627    627       H -> R (in MMAM; mut0;
FT                                dbSNP:rs372486357).
FT                                {ECO:0000269|PubMed:10923046,
FT                                ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022413.
FT   VARIANT     630    630       G -> E (in MMAM; mut0;
FT                                dbSNP:rs143023066).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:7912889}.
FT                                /FTId=VAR_004422.
FT   VARIANT     633    633       V -> G (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity;
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; does not alter
FT                                thermodynamic stability;
FT                                dbSNP:rs200055428).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004423.
FT   VARIANT     637    637       G -> E (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022414.
FT   VARIANT     637    637       G -> R (in MMAM; mut0;
FT                                dbSNP:rs781501004).
FT                                {ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_026627.
FT   VARIANT     638    638       F -> I (in MMAM; mut0).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022415.
FT   VARIANT     640    640       D -> Y (in MMAM; mut0;
FT                                dbSNP:rs865815395).
FT                                {ECO:0000269|PubMed:15643616}.
FT                                /FTId=VAR_022416.
FT   VARIANT     642    642       G -> R (in MMAM; mut-;
FT                                dbSNP:rs747897332).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286}.
FT                                /FTId=VAR_022417.
FT   VARIANT     648    648       G -> D (in MMAM; mut-; no effect on
FT                                protein abundance; decreased
FT                                methylmalonyl-CoA mutase activity; strong
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs766721811).
FT                                {ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:7912889}.
FT                                /FTId=VAR_004424.
FT   VARIANT     669    669       V -> E (in MMAM; mut0).
FT                                /FTId=VAR_004425.
FT   VARIANT     671    671       I -> V (in dbSNP:rs8589).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:11350191,
FT                                ECO:0000269|PubMed:1346616,
FT                                ECO:0000269|PubMed:1351030,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:1980486,
FT                                ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:2567699,
FT                                ECO:0000269|PubMed:9452100,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_004426.
FT   VARIANT     674    674       L -> F (in MMAM; decreased protein
FT                                abundance; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:22727635,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_075392.
FT   VARIANT     678    678       H -> R (in MMAM; mut-;
FT                                dbSNP:rs147094927).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_004427.
FT   VARIANT     684    684       E -> EL (in MMAM; mut-).
FT                                {ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004428.
FT   VARIANT     685    685       L -> R (in MMAM; mut-;
FT                                dbSNP:rs864309739).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:9554742}.
FT                                /FTId=VAR_004429.
FT   VARIANT     692    692       L -> P (in MMAM).
FT                                {ECO:0000269|PubMed:26615597}.
FT                                /FTId=VAR_075393.
FT   VARIANT     694    694       R -> L (in MMAM; mut-; decreased protein
FT                                abundance; loss of methylmalonyl-CoA
FT                                mutase activity; decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability).
FT                                {ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:27167370}.
FT                                /FTId=VAR_075394.
FT   VARIANT     694    694       R -> W (in MMAM; mut- and mut0; no effect
FT                                on protein abundance; loss of
FT                                methylmalonyl-CoA mutase activity;
FT                                decreased affinity for
FT                                adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs777758903).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:26615597,
FT                                ECO:0000269|PubMed:7912889,
FT                                ECO:0000269|PubMed:9285782}.
FT                                /FTId=VAR_004430.
FT   VARIANT     700    700       M -> K (in MMAM; mut-; no effect on
FT                                protein abundance; loss of methylmalonyl-
FT                                CoA mutase activity; decreased affinity
FT                                for adenosylcob(III)alamin; alters
FT                                thermodynamic stability;
FT                                dbSNP:rs140600746).
FT                                {ECO:0000269|PubMed:15643616,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:17113806,
FT                                ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_022418.
FT   VARIANT     703    703       G -> R (in MMAM; mut0;
FT                                dbSNP:rs121918255).
FT                                {ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:7909321}.
FT                                /FTId=VAR_004431.
FT   VARIANT     717    717       G -> V (in MMAM; mut-; no effect on
FT                                protein abundance; interfers with the
FT                                binding of the cofactor to the apoenzyme;
FT                                decreased methylmalonyl-CoA mutase
FT                                activity; strong decreased affinity for
FT                                adenosylcob(III)alamin; decreased
FT                                thermodynamic stability;
FT                                dbSNP:rs121918252).
FT                                {ECO:0000269|PubMed:1346616,
FT                                ECO:0000269|PubMed:1351030,
FT                                ECO:0000269|PubMed:16281286,
FT                                ECO:0000269|PubMed:25125334,
FT                                ECO:0000269|PubMed:9285782,
FT                                ECO:0000269|PubMed:9452100}.
FT                                /FTId=VAR_004432.
FT   VARIANT     723    723       G -> D (in MMAM; decreased protein
FT                                expression; decreased methylmalonyl-CoA
FT                                mutase activity).
FT                                {ECO:0000269|PubMed:28101778}.
FT                                /FTId=VAR_078349.
FT   VARIANT     736    736       L -> F (in MMAM; dbSNP:rs753461919).
FT                                {ECO:0000269|PubMed:25125334}.
FT                                /FTId=VAR_077232.
FT   CONFLICT    153    153       V -> L (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    236    236       E -> D (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    274    277       ILEL -> FWSW (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       Y -> H (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    505    505       I -> T (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    516    516       E -> G (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       F -> Y (in Ref. 2; AAA99226).
FT                                {ECO:0000305}.
FT   HELIX        30     33       {ECO:0000244|PDB:3BIC}.
FT   HELIX        41     50       {ECO:0000244|PDB:2XIJ}.
FT   TURN         51     53       {ECO:0000244|PDB:2XIQ}.
FT   HELIX        56     59       {ECO:0000244|PDB:2XIJ}.
FT   HELIX        75     78       {ECO:0000244|PDB:2XIJ}.
FT   STRAND       95     98       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      101    103       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      106    111       {ECO:0000244|PDB:2XIQ}.
FT   HELIX       116    128       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      133    136       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       140    143       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       151    153       {ECO:0000244|PDB:2XIJ}.
FT   TURN        154    159       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      160    162       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       167    173       {ECO:0000244|PDB:2XIJ}.
FT   TURN        174    176       {ECO:0000244|PDB:2XIJ}.
FT   TURN        179    181       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      183    186       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       192    205       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       210    212       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      214    217       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       222    226       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       235    252       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      259    262       {ECO:0000244|PDB:2XIQ}.
FT   HELIX       264    269       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       273    293       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       298    301       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       302    304       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      307    311       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       315    337       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       342    345       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      349    353       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      360    362       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       365    379       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      383    386       {ECO:0000244|PDB:2XIJ}.
FT   TURN        390    394       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       399    415       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       418    420       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      421    423       {ECO:0000244|PDB:2XIJ}.
FT   TURN        424    427       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       429    451       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       455    461       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       463    481       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      482    484       {ECO:0000244|PDB:2XIJ}.
FT   TURN        487    489       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      490    492       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       508    524       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       527    543       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       548    557       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       562    573       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       586    591       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       595    611       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      616    620       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       629    640       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      644    647       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       654    663       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      667    673       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       678    691       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      697    704       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       707    709       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       710    716       {ECO:0000244|PDB:2XIJ}.
FT   STRAND      720    722       {ECO:0000244|PDB:2XIJ}.
FT   HELIX       728    744       {ECO:0000244|PDB:2XIJ}.
SQ   SEQUENCE   750 AA;  83134 MW;  B5909729C08B562F CRC64;
     MLRAKNQLFL LSPHYLRQVK ESSGSRLIQQ RLLHQQQPLH PEWAALAKKQ LKGKNPEDLI
     WHTPEGISIK PLYSKRDTMD LPEELPGVKP FTRGPYPTMY TFRPWTIRQY AGFSTVEESN
     KFYKDNIKAG QQGLSVAFDL ATHRGYDSDN PRVRGDVGMA GVAIDTVEDT KILFDGIPLE
     KMSVSMTMNG AVIPVLANFI VTGEEQGVPK EKLTGTIQND ILKEFMVRNT YIFPPEPSMK
     IIADIFEYTA KHMPKFNSIS ISGYHMQEAG ADAILELAYT LADGLEYSRT GLQAGLTIDE
     FAPRLSFFWG IGMNFYMEIA KMRAGRRLWA HLIEKMFQPK NSKSLLLRAH CQTSGWSLTE
     QDPYNNIVRT AIEAMAAVFG GTQSLHTNSF DEALGLPTVK SARIARNTQI IIQEESGIPK
     VADPWGGSYM MECLTNDVYD AALKLINEIE EMGGMAKAVA EGIPKLRIEE CAARRQARID
     SGSEVIVGVN KYQLEKEDAV EVLAIDNTSV RNRQIEKLKK IKSSRDQALA ERCLAALTEC
     AASGDGNILA LAVDASRARC TVGEITDALK KVFGEHKAND RMVSGAYRQE FGESKEITSA
     IKRVHKFMER EGRRPRLLVA KMGQDGHDRG AKVIATGFAD LGFDVDIGPL FQTPREVAQQ
     AVDADVHAVG ISTLAAGHKT LVPELIKELN SLGRPDILVM CGGVIPPQDY EFLFEVGVSN
     VFGPGTRIPK AAVQVLDDIE KCLEKKQQSV
//
